InfuSystem Holdings, Inc. (INFU) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Margin | 58.40 percent | FY2026-Q1 |
| Device Solutions Net Revenue | 11.58M | FY2026-Q1 |
| Non-GAAP Adjusted Earnings Before Interest, Income Taxes, Depreciation and Amortization | 6.4M | FY2026-Q1 |
| Non-GAAP Adjusted Earnings Before Interest, Income Taxes, Depreciation and Amortization Margin | 18.90 percent | FY2026-Q1 |
| Patient Services Net Revenue | 22.11M | FY2026-Q1 |
| Device Solutions Gross Margin | 46.30 percent | FY2026-Q1 |
| Patient Services Gross Margin | 64.80 percent | FY2026-Q1 |
| Device Solutions Gross Profit | 6.5M | FY2025-Q4 |
| Patient Services Gross Profit | 13.9M | FY2025-Q4 |
Back to INFU overview · INFU earnings · INFU holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.